These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8777672)

  • 1. Prophylactic indomethacin: systematic review and meta-analysis.
    Fowlie PW
    Arch Dis Child Fetal Neonatal Ed; 1996 Mar; 74(2):F81-7. PubMed ID: 8777672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.
    Fowlie PW
    Cochrane Database Syst Rev; 2000; (2):CD000174. PubMed ID: 10796168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.
    Fowlie PW; Davis PG
    Cochrane Database Syst Rev; 2002; (3):CD000174. PubMed ID: 12137607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis.
    Fowlie PW; Davis PG
    Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F464-6. PubMed ID: 14602691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.
    Fowlie PW; Davis PG; McGuire W
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000174. PubMed ID: 20614421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.
    Bandstra ES; Montalvo BM; Goldberg RN; Pacheco I; Ferrer PL; Flynn J; Gregorios JB; Bancalari E
    Pediatrics; 1988 Oct; 82(4):533-42. PubMed ID: 3174314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infants.
    Hunt R; Hey E
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004343. PubMed ID: 20091562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants.
    Moya MP; Goldberg RN
    Ann Pharmacother; 2002 Feb; 36(2):218-24. PubMed ID: 11847937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.
    Schmidt B; Davis P; Moddemann D; Ohlsson A; Roberts RS; Saigal S; Solimano A; Vincer M; Wright LL;
    N Engl J Med; 2001 Jun; 344(26):1966-72. PubMed ID: 11430325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating extremely low birthweight infants with prophylactic indomethacin. Evidence for short term benefits only.
    McGuire W; Fowlie PW
    BMJ; 2002 Jan; 324(7329):60-1. PubMed ID: 11786435
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants.
    Mirza H; Laptook AR; Oh W; Vohr BR; Stoll BJ; Kandefer S; Stonestreet BS;
    Arch Dis Child Fetal Neonatal Ed; 2016 Sep; 101(5):F418-22. PubMed ID: 26733540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis.
    Mitra S; Florez ID; Tamayo ME; Aune D; Mbuagbaw L; Veroniki AA; Thabane L
    BMJ Open; 2016 Jul; 6(7):e011271. PubMed ID: 27456327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants.
    Jones LJ; Craven PD; Attia J; Thakkinstian A; Wright I
    Arch Dis Child Fetal Neonatal Ed; 2011 Jan; 96(1):F45-52. PubMed ID: 20876595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.
    Ohlsson A; Shah PS
    Cochrane Database Syst Rev; 2015 Mar; (3):CD010061. PubMed ID: 25758061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.